
Loading, please wait...

Loading, please wait...

This randomized trial evaluated whether a structured group cognitive-behavioral intervention could improve CPAP uptake and adherence in people newly diagnosed with obstructive sleep apnea. Participants received treatment as usual or treatment as usual plus two one-hour cognitive-behavioral sessions that incorporated education and experiences from actual CPAP users. At 28 days, the intervention group used CPAP for more hours and was more likely to initiate treatment. Measures of self-efficacy and social support also improved, suggesting that behavior and confidence can influence whether patients persist with therapy. The study is clinically useful because it demonstrates that CPAP adherence is not purely a device problem. Patient beliefs, expectations, support and early experience all matter. This aligns closely with the NAPCON sleep symposium's message that CPAP adherence begins with counseling. The findings also help explain why a single educational message may be insufficient for some patients. In practice, clinicians can consider structured, repeated support, early troubleshooting and reinforcement of self-efficacy, particularly in patients who are hesitant or struggling during the first weeks of treatment.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This randomized trial evaluated whether a structured group cognitive-behavioral intervention could improve CPAP uptake and adherence in people newly diagnosed with obstructive sleep apnea. Participants received treatment as usual or treatment as usual plus two one-hour cognitive-behavioral sessions that incorporated education and experiences from actual CPAP users. At 28 days, the intervention group used CPAP for more hours and was more likely to initiate treatment. Measures of self-efficacy and social support also improved, suggesting that behavior and confidence can influence whether patients persist with therapy. The study is clinically useful because it demonstrates that CPAP adherence is not purely a device problem. Patient beliefs, expectations, support and early experience all matter. This aligns closely with the NAPCON sleep symposium's message that CPAP adherence begins with counseling. The findings also help explain why a single educational message may be insufficient for some patients. In practice, clinicians can consider structured, repeated support, early troubleshooting and reinforcement of self-efficacy, particularly in patients who are hesitant or struggling during the first weeks of treatment.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back